P4733Growth factors and atrophy-related genes are highly expressed in patients with HFpEF and are associated with elevated BNP and reduced exercise capacity and quality of life
Tarek Bekfani(University Hospital Magdeburg), P. Christian Schulze(Temple College), Tom Kretzschmar(Jena University Hospital), E.J Froeb(Jena University Hospital), Ali Hamadanchi(Friedrich Schiller University Jena), Jenny Nisser(Friedrich Schiller University Jena), Daniela Haase(Schiller International University), Günter Wolf(Jena University Hospital), Steffen Derlien(Friedrich Schiller University Jena), U. Smolenski(Friedrich Schiller University Jena), G. Lehmann(Jena University Hospital), Sven Moebius‐Winkler(Jena University Hospital)
Cited by 0
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889